Name | EG00229 |
---|---|
Synonyms |
(S)-2-(3-(benzo[c][1,2,5]thiadiazole-4-sulfonamido)thiophene-2-carboxamido)-5-guanidinopentanoic acid
EG00229 N2-({3-[(2,1,3-Benzothiadiazol-4-ylsulfonyl)amino]-2-thienyl}carbonyl)-L-arginine L-Arginine, N2-[[3-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-2-thienyl]carbonyl]- MFCD18251520 N2-[[3-[(2,1,3-Benzothiadiazol-4-ylsulfonyl)amino]-2-thienyl]carbonyl]-L-arginine |
Description | EG00229 is a specific inhibitor of neuropilin-1 (NRP1)/VEGF-A interaction, inhibits the binding of biotinylated VEGFA to NRP1 with IC50 of 8 uM; also demonstrates to have functional effects on cell-migration and VEGF-R2 phosphorylation. |
---|---|
References | References 1. Powell J, et al. J Med Chem. 2018 May 10;61(9):4135-4154. 2. Jarvis A, et al. J Med Chem. 2010 Mar 11;53(5):2215-26. View Related Products by Target VEGFR |
Density | 1.8±0.1 g/cm3 |
---|---|
Molecular Formula | C17H19N7O5S3 |
Molecular Weight | 497.572 |
Exact Mass | 497.060974 |
LogP | 0.63 |
Index of Refraction | 1.810 |
RIDADR | NONH for all modes of transport |
---|